Drug Trial Radar · NCT00478647
Study of GA-GCB Enzyme Replacement Therapy in Type 1 Gaucher Disease Patients Previously Treated With Imiglucerase
Last checked: Nov 19, 2026Latest source record: Jun 10, 2021 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
40
Actual
Start
Jul 25, 2007
Primary completion
Jun 26, 2009
Study completion Jun 26, 2009
Sponsor
- Lead sponsor
- ShireTakeda (TAK)
- Sponsor type
- Industry
- First posted
- May 25, 2007
Design
- Study type
- Interventional
- Phase
- Phase 2 / Phase 3
- Allocation
- Not applicable (single group)
- Model
- Single group
- Masking
- None
- Primary purpose
- Treatment
- Who can join
- All sexes, from 2 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
Gaucher disease is a rare lysosomal storage disorder caused by the deficiency of the enzyme glucocerebrosidase (GCB). Due to the deficiency of functional GCB, glucocerebroside accumulates within macrophages leading to cellular engorgement, organomegaly, and organ system dysfunction. The purpose of this study is to evaluate the safety and efficacy of every other week dosing of GA-GCB (velaglucerase alfa) in participants with type 1 Gaucher disease who were previously treated with imiglucerase.
Conditions
- Gaucher Disease
Interventions
GA-GCB (velaglucerase alfa)Biological
15-60 U/kg, every other week via intravenous infusion
Primary outcomes
What the sponsor says the trial is designed to measure.
- Participants Who Experienced at Least One Adverse EventTime frame: Week 53
Locations
15 sites in 5 countries. Site status is shown where the registry gives one.
Regional Metabolic Center
Los Angeles, California
Children's Hospital Oakland
Oakland, California
Emory University
Decatur, Georgia
Feinberg School of Medicine
Chicago, Illinois
Children's of Minnesota
Minneapolis, Minnesota
Children's Mercy Hospital and Clinic
Kansas City, Missouri
NYU School of Medicine
New York, New York
Cincinatti Children's Hospital
Cincinnati, Ohio
Texas Children's Hospital
Houston, Texas
Medical Genetics/Pediatrics
Salt Lake City, Utah
Children's Hospital of Wisconsin
Milwaukee, Wisconsin
Shaare Zedek Medical Center
Jerusalem, Israel
Children's Memorial Health Institute
Warsaw, Poland
Hospital Universitario Miguel Servet
Zaragoza, Spain
The Royal Free Hospital
London, United Kingdom
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.